When patients present to the emergency department (ED) with sickle cell disease (SCD)–related pain, they often have been experiencing that pain for days, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
When patients present to the emergency department (ED) with sickle cell disease (SCD)—related pain, they often have been experiencing that pain for days, said C. Patrick Carroll, MD, director of psychiatric services, Sickle Cell Center for Adults, associate professor of psychiatry, Johns Hopkins Medicine.
Transcript
How should patients with acute pain related to sickle cell disease be treated when they arrive in the ED?
Probably the shortest and best answer is the way that their outpatient multidisciplinary team tells you to. Unfortunately, a lot of people with sickle cell disease don't have that outpatient multidisciplinary team. And so, first thing is we really need to try to establish that system of care.
The short answer is, shorter answer is, rapidly and aggressively. People with sickle cell disease who've come to the emergency room or in another acute care center, typically have been suffering with their pain for several days. And they've also probably had 2 or 3 crises that year that they never came in to see you about. So, they're there for a really good reason.
And so, the pain needs to be treated quickly and the standard is to try to get people their first dose of medicine after an evaluation in about 30 minutes, and then reevaluate it because the first dose often doesn't work. And among acute pain events, sickle cell crisis and some of the most long lasting you go on for days, and sometimes weeks. So, you're going to need to reevaluate people frequently, every hour probably at least, in order to make sure that the treatments working and establish a dose.
Most people will have been through this before, they will know what works for them, and hopefully they'll have worked with their multidisciplinary team to come up with an individualized pain plan that they can guide treatment. But by and large, people know what works for them, so it helps a lot to ask the patient.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
2 Commerce Drive
Cranbury, NJ 08512